• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AGA MEDICAL CORPORATION AMPLATZER SEPTAL OCCLUDER; TRANSCATHETER SEPTAL OCCLUDER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AGA MEDICAL CORPORATION AMPLATZER SEPTAL OCCLUDER; TRANSCATHETER SEPTAL OCCLUDER Back to Search Results
Model Number 9-ASD-014
Device Problem Unintended Movement (3026)
Patient Problem Blood Loss (2597)
Event Date 11/16/2018
Event Type  Injury  
Event Description
On (b)(6) 2018, a 14mm amplatzer septal occluder was implanted.At the end of procedure, blood was noticed in the endotracheal breathing tube; however, once the bleeding resolved the patient was extubated successfully.Post-procedure ct scan showed the device had embolized to the abdominal aorta.On (b)(6) 2018, the occluder was snared through the femoral artery without any complications.The patient is scheduled for percutaneous closure of the asd on (b)(6) 2018.The patient is reported to be stable.
 
Manufacturer Narrative
An event of embolization was reported.The results of the investigation are inconclusive since the device was not returned for analysis.The device history record was reviewed to ensure that each manufacturing and inspection operation was performed.Based on the information received, the cause of the reported incident could not be conclusively determined.
 
Event Description
On (b)(6) 2018, a 14mm amplatzer septal occluder was implanted.At the end of procedure, blood was noticed in the endotracheal breathing tube; however, once the bleeding resolved the patient was extubated successfully.Post-procedure ct scan showed the device had embolized to the abdominal aorta.On (b)(6) 2018, the occluder was snared through the femoral artery without any complications.The patient was scheduled for percutaneous closure of the asd on a later date.The patient is reported to be stable.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AMPLATZER SEPTAL OCCLUDER
Type of Device
TRANSCATHETER SEPTAL OCCLUDER
Manufacturer (Section D)
AGA MEDICAL CORPORATION
5050 nathan lane north
plymouth MN 55442
Manufacturer (Section G)
AGA MEDICAL CORPORATION
5050 nathan lane north
plymouth MN 55442
Manufacturer Contact
stephanie o' sullivan
5050 nathan lane north
plymouth, MN 55442
6517565400
MDR Report Key8139108
MDR Text Key129515205
Report Number2135147-2018-00233
Device Sequence Number1
Product Code MLV
UDI-Device Identifier05415067019226
UDI-Public05415067019226
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P000039
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 01/04/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/06/2018
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date07/31/2021
Device Model Number9-ASD-014
Device Catalogue Number9-ASD-014
Device Lot Number5616978
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Date Manufacturer Received12/06/2018
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured08/23/2016
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age61 YR
-
-